Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,580.70 +125.86 1.01%
S&P 500 1,332.42 +14.60 1.11%
Nasdaq 2,870.99 +33.46 1.18%
Ticker Volume Price Price Delta
STOXX 50 2,160.31 +12.39 0.58%
FTSE 100 5,391.14 +34.80 0.65%
DAX 6,396.84 +73.65 1.16%
Ticker Volume Price Price Delta
Nikkei 8,628.62 -28.46 -0.33%
TOPIX 723.84 -3.19 -0.44%
Hang Seng 19,055.50 +254.47 1.35%
Gold 1,555.80 +0.31%
EUR-USD 1.2476 -0.2118%
Nasdaq 2,870.99 +1.18%
DJIA 12,580.70 +1.01%
S&P 500 1,332.42 +1.11%
FTSE 100 5,391.14 +0.65%
STOXX 50 2,160.31 +0.58%
DAX 6,396.84 +1.16%
Oil (WTI) 90.73 -0.03%
U.S. 10-year 1.731% -0.007
BAC:US 7.44 +4.06%
FB:US 28.84 -9.62%

Elliott Seeks Adjournment of Actelion AGM Amid Asahi U.S. Case

Elliott Advisors (UK) Ltd. said Actelion Ltd. (ATLN)’s annual general meeting should be adjourned to “later in May or June” because of a “potential legal defeat” in Actelion’s U.S. court case with Asahi Kasei Pharma Corp. and called for “a full disclosure of the findings” from the trial, Elliott said in an e-mailed statement today.

An adjournment would give Actelion shareholders more time to consider the future of the company, Elliott said in the statement.

To contact the reporter on this story: Blanche Gatt in London at bgatt@bloomberg.net

To contact the editor responsible for this story: Colin Keatinge at ckeatinge@bloomberg.net.

Sponsored Links